Discordant scores for PD-L1 protein expression on tumor cells between cores from one patient were observed in 27% of cases, based on percentage of positive tumor cells, and in 15% of cases based on intensity of PD-L1 staining. This evidence concerns the gene CD274 and neoplasm.